In the current case-control study with 1032 HCC patients and 1060 cancer-free controls, we investigated whether miR-199a rs74723057 and MET rs1621 polymorphisms are associated with the risk of HCC in the population of South China. The gene discussed is MET; the disease is hepatocellular carcinoma.